National Pension Service boosted its position in Becton, Dickinson and Company (NYSE:BDX) by 10.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 171,227 shares of the medical instruments supplier’s stock after buying an additional 15,996 shares during the period. National Pension Service owned approximately 0.08% of Becton, Dickinson and worth $33,086,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of BDX. Parsec Financial Management Inc. purchased a new position in Becton, Dickinson and during the first quarter worth $214,000. Paragon Capital Management Ltd purchased a new position in Becton, Dickinson and during the first quarter worth $284,000. Dubuque Bank & Trust Co. increased its position in Becton, Dickinson and by 4.7% in the first quarter. Dubuque Bank & Trust Co. now owns 3,077 shares of the medical instruments supplier’s stock worth $564,000 after buying an additional 137 shares during the period. Mycio Wealth Partners LLC purchased a new position in Becton, Dickinson and during the first quarter worth $214,000. Finally, ProShare Advisors LLC increased its position in Becton, Dickinson and by 7.8% in the first quarter. ProShare Advisors LLC now owns 357,269 shares of the medical instruments supplier’s stock worth $65,537,000 after buying an additional 25,809 shares during the period. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Becton, Dickinson and Company (NYSE:BDX) traded down 0.56% during trading on Wednesday, reaching $197.78. The company had a trading volume of 293,372 shares. The stock has a market capitalization of $45.01 billion, a P/E ratio of 57.28 and a beta of 1.05. Becton, Dickinson and Company has a 12-month low of $161.29 and a 12-month high of $206.63. The stock has a 50 day moving average of $200.05 and a 200-day moving average of $189.42.

Becton, Dickinson and (NYSE:BDX) last posted its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, beating the Zacks’ consensus estimate of $2.44 by $0.02. The firm had revenue of $3.04 billion for the quarter, compared to the consensus estimate of $3.06 billion. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The company’s revenue was down 5.1% on a year-over-year basis. During the same period last year, the firm posted $2.35 EPS. On average, analysts forecast that Becton, Dickinson and Company will post $9.46 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 8th will be given a $0.73 dividend. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date is Thursday, September 7th. Becton, Dickinson and’s dividend payout ratio (DPR) is 83.43%.

WARNING: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/30/becton-dickinson-and-company-bdx-shares-bought-by-national-pension-service.html.

A number of research analysts have weighed in on the company. Bank of America Corporation reiterated a “buy” rating and set a $225.00 target price (up previously from $200.00) on shares of Becton, Dickinson and in a report on Friday, July 21st. BidaskClub upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating in a report on Monday, August 14th. Zacks Investment Research upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 target price on the stock in a report on Monday, July 17th. Cowen and Company reiterated a “buy” rating and set a $230.00 target price on shares of Becton, Dickinson and in a report on Monday, August 14th. Finally, Barclays PLC reiterated an “equal weight” rating and set a $210.00 target price (up previously from $205.00) on shares of Becton, Dickinson and in a report on Thursday, August 10th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. Becton, Dickinson and presently has a consensus rating of “Buy” and an average price target of $195.79.

In related news, insider Nabil Shabshab sold 6,149 shares of the stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $201.76, for a total value of $1,240,622.24. Following the transaction, the insider now directly owns 15,648 shares of the company’s stock, valued at approximately $3,157,140.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Linda M. Tharby sold 4,695 shares of the stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $200.48, for a total transaction of $941,253.60. Following the completion of the transaction, the executive vice president now directly owns 18,670 shares in the company, valued at $3,742,961.60. The disclosure for this sale can be found here. Insiders sold a total of 48,605 shares of company stock worth $9,718,986 over the last ninety days. Insiders own 1.40% of the company’s stock.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Stock Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related stocks with our FREE daily email newsletter.